Discontinued — last reported Q3 '17
Elevance Health Net premiums earned increased by 0.8% to $41.02B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $40.89B to $41.02B. Over 4 years (FY 2021 to FY 2025), Net premiums earned shows an upward trend with a 8.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growth in the member base or higher premium pricing, while a decrease may signal market share loss or competitive pricing pressure.
Represents the total revenue generated from insurance premiums after accounting for reinsurance cessions. This is the pr...
Standard across all health insurance peers; comparable to gross written premiums adjusted for reinsurance.
is_net_premiums_earned| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.53B | $30.40B | $30.77B | $32.79B | $33.08B | $33.72B | $33.65B | $35.87B | $36.59B | $35.26B | $35.14B | $35.70B | $35.42B | $36.81B | $36.25B | $40.89B | $41.27B | $41.79B | $40.69B | $41.02B |
| QoQ Change | — | +6.5% | +1.2% | +6.6% | +0.9% | +2.0% | -0.2% | +6.6% | +2.0% | -3.6% | -0.3% | +1.6% | -0.8% | +3.9% | -1.5% | +12.8% | +0.9% | +1.3% | -2.6% | +0.8% |
| YoY Change | — | — | — | — | +15.9% | +10.9% | +9.4% | +9.4% | +10.6% | +4.6% | +4.4% | -0.5% | -3.2% | +4.4% | +3.2% | +14.5% | +16.5% | +13.5% | +12.3% | +0.3% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Health Benefits Segment | $35.10B | $36.45B | $35.74B | $39.59B | $39.71B | $40.30B | $39.86B | $40.45B |
| Carelon Services Segment | $794.00M | $680.00M | $748.00M | $1.50B | $1.86B | $1.76B | $1.19B | $779.00M |
| Carelon Total | $794.00M | $680.00M | — | — | — | — | — | — |
| CarelonRx Segment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Corporate & Other | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $35.42B | $36.81B | $36.25B | $40.89B | $41.27B | $41.79B | $40.69B | $41.02B |
Carelon Total, Corporate & Other Segment, Segment Eliminations were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.